218 related articles for article (PubMed ID: 35688943)
1. IGF1R acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression.
Alfaro-Arnedo E; López IP; Piñeiro-Hermida S; Canalejo M; Gotera C; Sola JJ; Roncero A; Peces-Barba G; Ruíz-Martínez C; Pichel JG
Oncogene; 2022 Jul; 41(28):3625-3639. PubMed ID: 35688943
[TBL] [Abstract][Full Text] [Related]
2. Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation.
Hayakawa D; Takahashi F; Mitsuishi Y; Tajima K; Hidayat M; Winardi W; Ihara H; Kanamori K; Matsumoto N; Asao T; Ko R; Shukuya T; Takamochi K; Hayashi T; Suehara Y; Takeda Nakamura I; Ueno T; Kohsaka S; Mano H; Takahashi K
Thorac Cancer; 2020 Jan; 11(1):140-149. PubMed ID: 31758670
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.
Murakami A; Takahashi F; Nurwidya F; Kobayashi I; Minakata K; Hashimoto M; Nara T; Kato M; Tajima K; Shimada N; Iwakami S; Moriyama M; Moriyama H; Koizumi F; Takahashi K
PLoS One; 2014; 9(1):e86459. PubMed ID: 24489728
[TBL] [Abstract][Full Text] [Related]
4. NudCD1 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells through the Activation of IGF1R-ERK1/2.
He B; Xia S; Zhang Z
Pathobiology; 2020; 87(4):244-253. PubMed ID: 32634806
[TBL] [Abstract][Full Text] [Related]
5. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathways.
Zhou F; Nie L; Feng D; Guo S; Luo R
Oncol Rep; 2017 Sep; 38(3):1857-1866. PubMed ID: 28731178
[TBL] [Abstract][Full Text] [Related]
7. miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor.
Yuan Y; Shen Y; Xue L; Fan H
PLoS One; 2013; 8(9):e73604. PubMed ID: 24039995
[TBL] [Abstract][Full Text] [Related]
8. MiR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R.
Wang X; Wang Y; Lan H; Li J
Tumour Biol; 2014 Sep; 35(9):8765-70. PubMed ID: 24874051
[TBL] [Abstract][Full Text] [Related]
9. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
10. Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer.
Tran TN; Selinger CI; Yu B; Ng CC; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
J Clin Pathol; 2014 Nov; 67(11):985-91. PubMed ID: 25118293
[TBL] [Abstract][Full Text] [Related]
11. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
12. Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.
Vilmar A; Santoni-Rugiu E; Cillas JG; Huarriz M; Sørensen JB
Anticancer Res; 2014 Jun; 34(6):2991-6. PubMed ID: 24922664
[TBL] [Abstract][Full Text] [Related]
13. Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts.
Piñeiro-Hermida S; Bosso G; Sánchez-Vázquez R; Martínez P; Blasco MA
Cell Death Differ; 2023 Jun; 30(6):1585-1600. PubMed ID: 37085672
[TBL] [Abstract][Full Text] [Related]
14. Circ-IGF1R inhibits cell invasion and migration in non-small cell lung cancer.
Xu Z; Xiang W; Chen W; Sun Y; Qin F; Wei J; Yuan L; Zheng L; Li S
Thorac Cancer; 2020 Apr; 11(4):875-887. PubMed ID: 32107851
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Igf1r in Bronchiolar Epithelial Regeneration: Role during Repair Kinetics after Selective Club Cell Ablation.
López IP; Piñeiro-Hermida S; Pais RS; Torrens R; Hoeflich A; Pichel JG
PLoS One; 2016; 11(11):e0166388. PubMed ID: 27861515
[TBL] [Abstract][Full Text] [Related]
16. The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival.
Sachdev D; Zhang X; Matise I; Gaillard-Kelly M; Yee D
Oncogene; 2010 Jan; 29(2):251-62. PubMed ID: 19838209
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
[TBL] [Abstract][Full Text] [Related]
18. Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma.
Zhou Y; Zhang Z; Wang N; Chen J; Zhang X; Guo M; John Zhong L; Wang Q
Cell Death Dis; 2018 Apr; 9(4):429. PubMed ID: 29559623
[TBL] [Abstract][Full Text] [Related]
19. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
20. Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma.
Zumsteg A; Caviezel C; Pisarsky L; Strittmatter K; García-Echeverría C; Hofmann F; Christofori G
Mol Cancer Res; 2012 Jun; 10(6):800-9. PubMed ID: 22562956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
